Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Bipolar disorder, type II with diagnosis confirmed by SCAN interview
• Age 18-65 years
• Habile (i.e., able to give informed consent)
• Speaks Danish
Locations
Other Locations
Denmark
Psychiatric Center Copenhagen
RECRUITING
Copenhagen
Contact Information
Primary
Lars Vedel Kessing, professor, MD, DMSc.
lars.vedel.kessing@regionh.dk
+45 38 64 70 81
Time Frame
Start Date: 2024-05-08
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 200
Treatments
Experimental: Lithium
tablet
Active_comparator: Lamotrigine
tablet
Related Therapeutic Areas
Sponsors
Leads: Mental Health Services in the Capital Region, Denmark